...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome
【24h】

Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome

机译:乙型肝炎后迟发抗惊厥药超敏综合征的肝肾衰竭患者

获取原文
获取原文并翻译 | 示例
           

摘要

Anticonvulsant hypersensitivity syndrome is an adverse drug reaction usually occurring from 1 to 8 weeks after exposure to antiepileptic drugs. It can threaten life by affecting the liver, kidneys, central nervous system or lungs. We present a 47-year-old patient treated with phenytoin, lamotrigine and clobazam for 7 years. He presented with hepatic and renal failure in relation to this syndrome demonstrated by renal biopsy. Prognosis was excellent due to an early diagnosis leading to cessation of the causative agents. Levetiracetam was started with a good response.
机译:抗惊厥药超敏反应综合征是一种药物不良反应,通常在接触抗癫痫药后1至8周内发生。它可以通过影响肝脏,肾脏,中枢神经系统或肺部来威胁生命。我们现为一名47岁的患者,接受苯妥英钠,拉莫三嗪和克罗巴定治疗7年。他表现出与这种综合征有关的肝肾衰竭,并通过肾脏活检证实。由于早期诊断导致病原体的停止,因此预后极好。左乙拉西坦开始反应良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号